Evidence map›Paper›PMID 22426004›Full record

ArticleDevelopmental biology2012

Characterization and regulation of the hb9/mnx1 beta-cell progenitor specific enhancer in zebrafish.

Valeriya Arkhipova, Björn Wendik, Nathalie Devos, Olivier Ek, Bernard Peers, Dirk Meyer

Open access · hybridAbstract read
In one paragraph

Article in Developmental biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. SCGN deficiency is a risk factor for autism spectrum disorder.Signal transduction and targeted therapy · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. SNX27-FERM-SNX1 complex structure rationalizes divergent trafficking pathways by SNX17 and SNX27.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Structural and mechanistic insights into secretagogin-mediated exocytosis.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Article
  15. Article
  16. Structural and functional studies of TBC1D23 C-terminal domain provide a link between endosomal trafficking and PCH.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. STIM1 Is Required for Remodeling of the Endoplasmic Reticulum and Microtubule Cytoskeleton in Steering Growth Cones.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  18. Article
  19. Article
  20. Development (Cambridge, England) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Valeriya ArkhipovaInstitute for Molecular Biology/CMBI, Technikerstr. 25, University of Innsbruck, 6020 Innsbruck, Austria. A.Valeriya@gmx.de
Björn Wendik
Nathalie Devos
Olivier Ek
Bernard Peers
Dirk Meyer
University of Liège · BEUniversität Innsbruck · ATUniversity of Freiburg · DE

Funding

Austrian Science Fund FWF P 20492
6 · The paper itself

Abstract

Differentiation of insulin producing beta-cells is a genetically well defined process that involves functions of various conserved transcription factors. Still, the transcriptional mechanisms underlying specification and determination of beta-cell fate are poorly defined. Here we provide the description of a beta-cell progenitor specific enhancer as a model to study initial steps of beta-cell differentiation. We show that evolutionary non-conserved upstream sequences of the zebrafish hb9 gene are required and sufficient for regulating expression in beta-cells prior to the onset of insulin expression. This enhancer contains binding sites for paired-box transcription factors and two E-boxes that in EMSA studies show interaction with Pax6b and NeuroD, respectively. We show that Pax6b is a potent activator of endodermal hb9 expression and that this activation depends on the beta-cell enhancer. Using genetic approaches we show that pax6b is crucial for maintenance but not induction of pancreatic hb9 transcription. As loss of Pax6b or Hb9 independently results in the loss of insulin expression, the data reveal a novel cross-talk between the two essential regulators of early beta-cell differentiation. While we find that the known pancreatic E-box binding proteins NeuroD and Ngn3 are not required for hb9 expression we also show that removal of both E-boxes selectively eliminates pancreatic specific reporter expression. The data provide evidence for an Ngn3 independent pathway of beta-cell specification that requires function of currently not specified E-box binding factors.

Indexed as

Insulin-Secreting CellsAnimalsAnimals, Genetically ModifiedBasic Helix-Loop-Helix ProteinsCell DifferentiationCell LineageEye ProteinsHomeodomain ProteinsIslets of LangerhansNerve Tissue ProteinsPaired Box Transcription FactorsPAX6 Transcription FactorRepressor ProteinsSignal TransductionStem CellsTranscription FactorsBasic Helix-Loop-Helix ProteinsEye ProteinsHomeodomain ProteinsMnx1 protein, zebrafishNerve Tissue ProteinsNeurogenic differentiation factor 1Paired Box Transcription FactorsPAX6 Transcription FactorRepressor ProteinsTranscription FactorsZebrafish Proteins

Identifiers

PMID22426004
PMCPMC3327876
OpenAlexW2058763482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.